273 related articles for article (PubMed ID: 9465532)
1. Resistance to quinolones in pathogens causing urinary tract infections.
Kapoor H; Aggarwal P
J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
Tayfour M; Yuce A; Yulug N
Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
[TBL] [Abstract][Full Text] [Related]
4. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
Srinivasa H; Parija SC; Bhattacharya S; Sehgal R
J Commun Dis; 1999 Mar; 31(1):45-7. PubMed ID: 10810586
[TBL] [Abstract][Full Text] [Related]
5. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital.
Al-Tawfiq JA; Anani AA
Chemotherapy; 2009; 55(2):127-31. PubMed ID: 19188712
[TBL] [Abstract][Full Text] [Related]
8. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility pattern of urinary isolates in Imphal (Manipur), India.
Yengkokpam C; Ingudam D; Yengkokpam IS; Jha BK
Nepal Med Coll J; 2007 Sep; 9(3):170-2. PubMed ID: 18092433
[TBL] [Abstract][Full Text] [Related]
10. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
11. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
Tunçkanat F; Yuluğ N
Mikrobiyol Bul; 1988; 22(3):187-92. PubMed ID: 3252111
[TBL] [Abstract][Full Text] [Related]
12. [Trends and changes in antimicrobial resistance of clinical isolates from 11 hospitals in Beijing area].
Zhang F; Jin S; Wu Q
Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):327-31. PubMed ID: 9772484
[TBL] [Abstract][Full Text] [Related]
13. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Brothers AM; Gibbs PS; Wooley RE
Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O
Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
18. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial resistance of agents causing urinary tract infections in 11 Chilean hospitals. PRONARES project].
Valdivieso F; Trucco O; Prado V; Díaz MC; Ojeda A
Rev Med Chil; 1999 Sep; 127(9):1033-40. PubMed ID: 10752265
[TBL] [Abstract][Full Text] [Related]
20. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
Prado V; Trucco O; Durán C; Mamani R; Royer M;
Rev Med Chil; 2001 Aug; 129(8):877-85. PubMed ID: 11680961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]